行動リハビリテーション市場 - 世界の産業規模、シェア、動向、機会、予測：行動障害の種類別、ヘルスケア環境別、治療方法別、地域別、競合別、2020年～2030年

世界の行動リハビリテーション市場は、2024年に2,254億2,000万米ドルと評価され、2030年までのCAGRは6.07%で、予測期間中に目覚ましい成長を予測しています。

行動リハビリテーションは、個人の幸福を脅かす特定の学習行動に対処するために採用される心理療法的手法です。このアプローチには、カウンセリング、薬物療法、強化、罰、モデリングを含むさまざまな支援サービスが含まれます。その目的は、個人の心理的条件付けを修正し、自己破壊的で不健康な行動の発生を抑えることです。過敏性、不適切な行動、薬物乱用、抑うつ、不安、衝動性、攻撃性、多動性、悲嘆に関連するパターンを特定し対処することで、行動リハビリテーションは個人の感情や行動を管理する効果的な戦略を身につけさせ、人格障害、気分障害、注意欠陥障害を治療します。行動リハビリテーションは、後天性脳損傷の後治療に関連し、特に患者の感情状態の変化に対処することに重点を置いています。この治療法では、患者が家族、同僚、友人などに課題を与える可能性のある不適切な行動を効果的に管理するスキルを習得するのを支援します。過敏性の増大、気分の変動、情緒不安定、不適切な行動への関与などの症状発現は、行動リハビリテーションによって効果的に対処できる問題のひとつです。

市場促進要因

精神疾患の有病率の増加

主な市場課題

患者登録の不足

主要市場動向

デジタル解毒プログラムの増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の行動リハビリテーション市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 行動障害の種類別（不安障害、気分障害、物質乱用障害、人格障害、注意欠陥障害）
  • ヘルスケア環境別（外来行動リハビリテーション、入院行動リハビリテーション、在宅行動リハビリテーション）
  • 治療方法別（カウンセリング、薬物療法、サポートサービス、その他の治療方法）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の行動リハビリテーション市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の行動リハビリテーション市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の行動リハビリテーション市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の行動リハビリテーション市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの行動リハビリテーション市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Allergan, Inc.
• Novartis AG
• Taro Pharmaceutical Industries
• Perrigo Company plc
• Zynerba Pharmaceuticals
• Apotex Inc.
• Sandoz AG
• Strides Arcolab Ltd.
• TOLMAR Pharmaceuticals, Inc.
• Limbix Health Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Behavioural Rehabilitation Market was valued at USD 225.42 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.07% through 2030. Behavioral rehabilitation is a psychotherapeutic technique employed to address specific learned behaviors that pose a threat to an individual's well-being. This approach encompasses counseling, medication, and a range of support services, including reinforcement, punishment, and modeling. Its aim is to modify an individual's psychological conditioning, reducing the occurrence of self-destructive and unhealthy behaviors. By identifying and addressing patterns associated with irritability, inappropriate actions, substance abuse, depression, anxiety, impulsivity, aggression, hyperactivity, and grief, behavioral rehabilitation equips individuals with effective strategies to manage their emotions and actions, treating personality, mood, and attention deficit disorders. Behavioral rehabilitation pertains to the post-treatment of acquired brain injuries, with a specific focus on addressing changes in the patient's emotional state. This form of treatment aids patients in acquiring skills to effectively manage inappropriate actions that may pose challenges to their family members, co-workers, friends, and others. Symptomatic manifestations such as increased irritability, mood swings, emotional lability, and engaging in inappropriate behaviors are among the issues that can be effectively addressed through behavioral rehabilitation.

Key Market Drivers

Increase in the Prevalence of Mental Health Disorders

The rise in the prevalence of mental health disorders worldwide serves as a significant driver for the growth of the behavioral rehabilitation market. For instance, according to the NIH, over one in five U.S. adults-approximately 59.3 million people or 23.1% of the adult population-were living with a mental illness in 2022. This statistic highlights the widespread impact of mental health conditions across the country and underscores the urgent need for accessible, effective mental health services and support systems to address the growing demand for care. The emergence of various internet interventions for treating common mental disorders, particularly in remote patient monitoring and easy accessibility, along with the widespread adoption of cost-effective online counseling sessions, contribute to the accelerated market growth. For instance, in September 2023, Praesum Healthcare Services, LLC acquired Beacon Point Recovery Center, LLC, a behavioral health provider network based in Philadelphia, U.S. The acquisition aims to expand Praesum's footprint in the behavioral health sector and enhance access to quality mental health and addiction treatment services in the region. The increasing prevalence of anxiety, dementia, depression, and other psychological disorders among the population is a key driver for market growth. The growing preference for partial hospitalization programs (PHPs) among patients is bolstering market expansion. These multi-day programs, offered by rehabilitation centers and hospitals, aim to facilitate emotional regulation, conflict resolution, anger management, and substance abuse treatment. In line with this, various government and non-government organizations also organize camps to provide behavioral rehabilitation for individuals with post-traumatic stress disorder (PTSD) and drug addiction, thereby contributing to market growth. The availability of online counseling services acts as another growth-inducing factor. With the onset of the Covid-19 pandemic, individuals are increasingly adopting online platforms to access timely treatment and recovery support.

Key Market Challenges

Lack of Patient Enrollment

The lack of patient enrollment hinders the growth of behavioral rehabilitation programs. Patient enrollment refers to the process of recruiting and enrolling individuals into these programs for treatment and intervention. This challenge can impact the effectiveness, reach, and sustainability of behavioral rehabilitation efforts. Low patient enrollment can result in a limited number of individuals accessing behavioral rehabilitation services. This restricts the availability of treatment options for those in need and can contribute to unmet mental health and behavioral health needs. Behavioral rehabilitation programs often require significant resources, including trained professionals, facilities, and support staff. A lack of patient enrollment means that these resources might be underutilized, leading to inefficiencies and decreased cost-effectiveness. Many behavioral rehabilitation programs rely on patient fees, insurance reimbursements, or government funding to operate. A lack of patient enrollment can strain the financial sustainability of programs, potentially leading to reduced services or closure.

Key Market Trends

Increasing Number of Digital Detoxification Programs

The growing prevalence of digital detoxification programs is a significant driver of market growth in the behavioral rehabilitation sector. Internet and social media addictions have seen a surge due to global technological advancements, impacting individuals, particularly teenagers and young adults who are tech-savvy. Digital detox programs play a crucial role in addressing internet addiction, with the Chinese government taking the lead in implementing boot camps specifically targeting young adults. The focus on digital detoxification programs in Asia is expected to prompt other countries worldwide to follow suit, resulting in an increased number of digital rehabilitation programs and driving market growth throughout the forecast period.

Key Market Players

Allergan, Inc.

Novartis AG

Taro Pharmaceutical Industries

Perrigo Company plc

Zynerba Pharmaceuticals

Apotex Inc.

Sandoz AG

Strides Arcolab Ltd.

TOLMAR Pharmaceuticals, Inc.

Limbix Health Inc

Report Scope:

In this report, the Global Behavioural Rehabilitation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Behavioural Rehabilitation Market, By Type of Behavioural Disorder:

• Anxiety Disorder
• Mood Disorder
• Substance Abuse Disorder
• Personality Disorder
• Attention Deficit Disorder

Behavioural Rehabilitation Market, By Healthcare Setting:

• Outpatient Behavioural Rehabilitation
• Inpatient Behavioural Rehabilitation
• Residential Behavioural Rehabilitation

Behavioural Rehabilitation Market, By Treatment Method:

• Counselling
• Medication
• Support Services
• Other Treatment Methods

Behavioural Rehabilitation Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Behavioural Rehabilitation Market.

Available Customizations:

Global Behavioural Rehabilitation market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Behavioural Rehabilitation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type of Behavioural Disorder (Anxiety Disorder, Mood Disorder, Substance Abuse Disorder, Personality Disorder, and Attention Deficit Disorder)
  • 5.2.2. By Healthcare Setting (Outpatient Behavioural Rehabilitation, Inpatient Behavioural Rehabilitation, and Residential Behavioural Rehabilitation)
  • 5.2.3. By Treatment Method (Counselling, Medication, Support Services, and Other Treatment Methods)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Behavioural Rehabilitation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type of Behavioural Disorder
  • 6.2.2. By Healthcare Setting
  • 6.2.3. By Treatment Method
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Behavioural Rehabilitation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type of Behavioural Disorder
      • 6.3.1.2.2. By Healthcare Setting
      • 6.3.1.2.3. By Treatment Method
  • 6.3.2. Canada Behavioural Rehabilitation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type of Behavioural Disorder
      • 6.3.2.2.2. By Healthcare Setting
      • 6.3.2.2.3. By Treatment Method
  • 6.3.3. Mexico Behavioural Rehabilitation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type of Behavioural Disorder
      • 6.3.3.2.2. By Healthcare Setting
      • 6.3.3.2.3. By Treatment Method

7. Europe Behavioural Rehabilitation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type of Behavioural Disorder
  • 7.2.2. By Healthcare Setting
  • 7.2.3. By Treatment Method
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Behavioural Rehabilitation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type of Behavioural Disorder
      • 7.3.1.2.2. By Healthcare Setting
      • 7.3.1.2.3. By Treatment Method
  • 7.3.2. United Kingdom Behavioural Rehabilitation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type of Behavioural Disorder
      • 7.3.2.2.2. By Healthcare Setting
      • 7.3.2.2.3. By Treatment Method
  • 7.3.3. Italy Behavioural Rehabilitation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type of Behavioural Disorder
      • 7.3.3.2.2. By Healthcare Setting
      • 7.3.3.2.3. By Treatment Method
  • 7.3.4. France Behavioural Rehabilitation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type of Behavioural Disorder
      • 7.3.4.2.2. By Healthcare Setting
      • 7.3.4.2.3. By Treatment Method
  • 7.3.5. Spain Behavioural Rehabilitation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type of Behavioural Disorder
      • 7.3.5.2.2. By Healthcare Setting
      • 7.3.5.2.3. By Treatment Method

8. Asia-Pacific Behavioural Rehabilitation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type of Behavioural Disorder
  • 8.2.2. By Healthcare Setting
  • 8.2.3. By Treatment Method
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Behavioural Rehabilitation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type of Behavioural Disorder
      • 8.3.1.2.2. By Healthcare Setting
      • 8.3.1.2.3. By Treatment Method
  • 8.3.2. India Behavioural Rehabilitation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type of Behavioural Disorder
      • 8.3.2.2.2. By Healthcare Setting
      • 8.3.2.2.3. By Treatment Method
  • 8.3.3. Japan Behavioural Rehabilitation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type of Behavioural Disorder
      • 8.3.3.2.2. By Healthcare Setting
      • 8.3.3.2.3. By Treatment Method
  • 8.3.4. South Korea Behavioural Rehabilitation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type of Behavioural Disorder
      • 8.3.4.2.2. By Healthcare Setting
      • 8.3.4.2.3. By Treatment Method
  • 8.3.5. Australia Behavioural Rehabilitation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type of Behavioural Disorder
      • 8.3.5.2.2. By Healthcare Setting
      • 8.3.5.2.3. By Treatment Method

9. South America Behavioural Rehabilitation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type of Behavioural Disorder
  • 9.2.2. By Healthcare Setting
  • 9.2.3. By Treatment Method
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Behavioural Rehabilitation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type of Behavioural Disorder
      • 9.3.1.2.2. By Healthcare Setting
      • 9.3.1.2.3. By Treatment Method
  • 9.3.2. Argentina Behavioural Rehabilitation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type of Behavioural Disorder
      • 9.3.2.2.2. By Healthcare Setting
      • 9.3.2.2.3. By Treatment Method
  • 9.3.3. Colombia Behavioural Rehabilitation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type of Behavioural Disorder
      • 9.3.3.2.2. By Healthcare Setting
      • 9.3.3.2.3. By Treatment Method

10. Middle East and Africa Behavioural Rehabilitation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type of Behavioural Disorder
  • 10.2.2. By Healthcare Setting
  • 10.2.3. By Treatment Method
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Behavioural Rehabilitation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type of Behavioural Disorder
      • 10.3.1.2.2. By Healthcare Setting
      • 10.3.1.2.3. By Treatment Method
  • 10.3.2. Saudi Arabia Behavioural Rehabilitation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type of Behavioural Disorder
      • 10.3.2.2.2. By Healthcare Setting
      • 10.3.2.2.3. By Treatment Method
  • 10.3.3. UAE Behavioural Rehabilitation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type of Behavioural Disorder
      • 10.3.3.2.2. By Healthcare Setting
      • 10.3.3.2.3. By Treatment Method

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Allergan, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Novartis AG
• 14.3. Taro Pharmaceutical Industries
• 14.4. Perrigo Company plc
• 14.5. Zynerba Pharmaceuticals
• 14.6. Apotex Inc.
• 14.7. Sandoz AG
• 14.8. Strides Arcolab Ltd.
• 14.9. TOLMAR Pharmaceuticals, Inc.
• 14.10. Limbix Health Inc.

15. Strategic Recommendations

16. About Us & Disclaimer